Stage IIB Prostate Cancer Completed Phase 2 Trials for Phenelzine (DB00780)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02217709Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate CancerTreatment